Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Guinea ends mpox outbreak more than two years after first case

    November 21, 2026

    WFP warns funding gaps will leave millions hungry in 2027

    November 21, 2026

    Chip boom lifts South Korea into $1 trillion export club

    November 21, 2026
    Facebook X (Twitter) Instagram
    • Home
    • Contact Us
    Irbid DailyIrbid Daily
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Irbid DailyIrbid Daily
    Home » Hypertension breakthrough with biannual injections to replace daily pills
    Health

    Hypertension breakthrough with biannual injections to replace daily pills

    November 20, 2023

    In a significant medical breakthrough, an investigational drug, zilebesiran, has shown remarkable efficacy in reducing high blood pressure with just a single dose lasting up to six months. This finding, presented at the American Heart Association’s Scientific Sessions 2023, is a beacon of hope for the over one billion people worldwide grappling with hypertension. Dr. George L. Bakris, a leading figure in hypertension research, highlights a critical issue: more than 70% of hypertension patients fail to adhere to their medication regimens.

    Hypertension breakthrough with biannual injections to replace daily pills

    This non-compliance exacerbates risks associated with uncontrolled high blood pressure, such as cardiovascular diseases, kidney damage, and vision issues. Dr. Jennifer Wong, a cardiologist, notes the challenge of maintaining medication routines, particularly when the benefits are not immediately perceptible. Zilebesiran operates by targeting angiotensinogen, a hormone crucial in blood pressure regulation.

    It effectively blocks the production of angiotensin II, a substance that, in excess, can lead to increased blood pressure. By hindering this process, zilebesiran offers a promising route to lowering and controlling high blood pressure levels. In a clinical trial involving 400 participants, zilebesiran demonstrated its ability to significantly reduce systolic blood pressure. Patients receiving this drug experienced notable blood pressure reductions without the need for additional medication. The results surpassed expectations, both in the duration and the magnitude of blood pressure decrease.

    Experts like Dr. Ian del Conde are optimistic about this pioneering approach, viewing it as a potential game-changer in hypertension management. The prospect of effectively treating high blood pressure with biannual injections is not only revolutionary but also addresses the longstanding issue of medication non-compliance. The implications of this research extend far beyond blood pressure control. If zilebesiran proves effective in reducing incidents of heart attacks and strokes, it could redefine hypertension treatment globally.

    As Dr. Chen points out, the efficacy of zilebesiran in maintaining normal blood pressure ranges without daily medication could revolutionize patient care and adherence. The advent of zilebesiran heralds a new chapter in the fight against hypertension. It promises a more manageable and patient-friendly approach, potentially transforming the lives of millions who struggle with high blood pressure and its associated risks.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email WhatsApp

    Related Posts

    Guinea ends mpox outbreak more than two years after first case

    November 21, 2026

    Ebola adds 60 cases in a day as Congo deaths hit 5,568

    November 18, 2026

    Ebola cases top 11,200 as Africa CDC warns of record outbreak

    November 16, 2026

    Yellow fever kills 18 across nine African nations, WHO says

    November 7, 2026
    Latest News

    Guinea ends mpox outbreak more than two years after first case

    November 21, 2026

    WFP warns funding gaps will leave millions hungry in 2027

    November 21, 2026

    Chip boom lifts South Korea into $1 trillion export club

    November 21, 2026

    Air Arabia Egypt launches Cairo to Al Ain flights soon

    November 20, 2026

    Botswana reviews proposed 33% power tariff hike today

    November 19, 2026

    PM Modi meets Prince and Princess of Wales for climate talks

    November 19, 2026

    Petrol price jump lifts South Africa inflation as SARB weighs rates

    November 18, 2026

    Ebola adds 60 cases in a day as Congo deaths hit 5,568

    November 18, 2026
    © 2026 Irbid Daily | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.